Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER

Study acronym: COVID-SER
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 8 of 8 entries Show 5 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Oct 10, 2026 to Jan 5, 2026
    • Enrollment target: estimated 550 to confirmed 517
    • Publications: details revised at 6 of 6 entries
    • Eligibility criteria expanded, about 5 words
  2. Trial status: Recruiting to Active, Not Recruitingv7 Show 6 more changesShow less
    • Primary completion date changed from estimate of Apr 9, 2023 to Apr 10, 2023
    • Study completion date: Apr 9, 2024 to Oct 10, 2026
    • Start date: Apr 9, 2020 to Apr 10, 2020
    • Secondary endpoints shortened, about 123 words
    • Site details revised
    • Publications: 1 to 6
  3. Primary completion date: Sep 9, 2020 to Apr 9, 2023
    • Study completion date: Sep 9, 2020 to Apr 9, 2024
    v6
  4. Re-verified, no change to tracked fieldsv5
  5. Enrollment target: 130 to 550
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints expanded, about 123 words
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Enrollment target: 400 to 130
    • Eligibility criteria expanded, about 15 words
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests
Trial Details
NCT Number NCT04341142
Lead Sponsor Hospices Civils de Lyon
Conditions
(from sponsor)		 CoV2 Positive Caregivers
Enrollment 517 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov